PALO ALTO, Calif., Dec. 14, 2012 /PRNewswire/ -- Dow Wilson, president and ceo of Varian Medical Systems (NYSE: VAR) is scheduled to present at the J. P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 7, at the Westin St. Francis Hotel in San Francisco.
Other participating executives will be Elisha Finney, executive vice president and cfo; and Spencer Sias, vice president of investor relations and corporate communications. The presentation will focus on the company's growth initiatives in oncology, X-ray imaging components and proton therapy.
The presentation will be webcast and may be accessed via the company website at www.varian.com/pt-pt/investor. Web conferences will be archived on the company website for a year. For automatic "e-mail alerts" regarding Varian news, events, and new investor materials on the website, investors can subscribe on the company website:
http://varian.investorroom.com/index.php?s=58. For additional information, contact investor relations at 1 650 424-5834.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
SOURCE Varian Medical Systems